Results 181 to 190 of about 45,788 (261)

Balancing transition and readmission: a comparative study of low-dose vs standard buprenorphine initiation for medically managed opioid withdrawal. [PDF]

J Addict Dis
Nichols T, Lynch ST, Groenendaal E, Towey E, Ferrando S.   +4 more
europepmc   +1 more source

Accelerated Weaning of Opioids to Reduce Pharmacologic Exposure for Neonatal Opioid Withdrawal Syndrome: A Randomized Clinical Trial. [PDF]

J Pediatr
Laptook AR, Czynski A, Chahine R, Greenberg RG, Smith PB, Oliveira E, Gabrio J, Eggleston B, Das A, Lee J, Lester B, Clark D, Walsh M, Ko H, Asher CC, Friedman H, Gentle S, Rao K, Katheria A, Benninger K, Jani S, Smith MC, Khan A, Talati A, Lodhi S, Mena F, England A, Parimi P, Kylat R, Harmon H, Mannan J, Howell MP, Wright T, Snowden J, ACT NOW Collaborative.   +34 more
europepmc   +1 more source

The role of 5-HT modulation in opioid withdrawal and neonatal opioid withdrawal syndrome: mechanisms and potential serotonergic targets. [PDF]

Expert Opin Investig Drugs
Lam K, Peltz G, Kraft WK.
europepmc   +1 more source

Rethinking Global Obesity Guidelines: Integrating Evidence, Equity and Precision (2014–2026)

Obesity Reviews, EarlyView.
Challenges and evidence in obesity guidelines. ABSTRACT Obesity remains a global health crisis characterized by substantial heterogeneity in diagnosis, management, and policy implementation. Although numerous national and international clinical practice guidelines have been published over the past decade, their translation into evidence‐based and ...
Rosero‐Revelo Ricardo, Tamayo Mateo, Henao Diana, Juan P. Polanco, Cortés David, Juan C. Alba, Giha Valeria, Camargo Camilo, Hernández Eder, Correa Ricardo, Nassar Ricardo, Cabandugama Peminda, Marcio L. Griebeler, Burguera Bartolome   +13 more
wiley   +1 more source

Opioid withdrawal as a barrier to harm reduction: Examining how overdose prevention behaviors are affected by withdrawal. [PDF]

Drug Alcohol Depend
Yi G, Dayton L, Scott-Wallace A, Davey-Rothwell M, Falade-Nwulia S, Latkin C.   +5 more
europepmc   +1 more source

Elevated Levels of Blood Neurofilament Light Chain in Substance‐Using Populations: A Systematic Review and Meta‐Analysis

Psychiatry and Clinical Neurosciences, EarlyView.
Substance‐use disorders are increasingly linked to structural and functional brain alterations consistent with neuroaxonal injury. Neurofilament light chain (NfL) is a sensitive blood‐based marker of axonal damage, but evidence in substance‐using populations remains fragmented.
João Antônio Valadão Leal, Thiago Wendt Viola, Rodrigo Grassi‐Oliveira   +2 more
wiley   +1 more source

Ketamine treatment for buprenorphine-precipitated opioid withdrawal: a case report. [PDF]

Front Psychiatry
Gbujie E, Vercollone L, Suzuki J.
europepmc   +1 more source

Intermittent theta burst stimulation to extend early ketamine response in treatment‐resistant depression: A preliminary enriched randomized, double‐blind, sham‐controlled trial

Psychiatry and Clinical Neurosciences, EarlyView.
Background Ketamine produces rapid antidepressant effects in treatment‐resistant depression (TRD), but these benefits diminish within days. Whether intermittent theta‐burst stimulation (iTBS) can sustain ketamine response and whether such effects are associated with changes in large‐scale brain networks are unclear.
Tung‐Ping Su, Mao‐Hsuan Huang, Wan‐Chen Chang, Wen‐Han Chang, Pei‐Chi Tu, Wei‐Shan Huang, Wei‐Chung Mao, Mu‐Hong Chen   +7 more
wiley   +1 more source

Mothers with Concurrent Opioid and Cocaine Use and Neonatal Opioid Withdrawal Syndrome. [PDF]

Children (Basel)
Rana D, DeBaer L, Pourcyrous M.
europepmc   +1 more source

[Treatment of opioid withdrawal].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2009
Shahram, Shaygani, Helge, Waal
openaire   +1 more source